Skip to main content
BICYCLE THERAPEUTICS PLC logo

BICYCLE THERAPEUTICS PLC — Investor Relations & Filings

Ticker · BCYC ISIN · US0887861088 LEI · 213800XKUI6R7GKC3E43 US Manufacturing
Filings indexed 598 across all filing types
Latest filing 2021-04-09 Director's Dealing
Country GB United Kingdom
Listing US BCYC

About BICYCLE THERAPEUTICS PLC

https://www.bicycletherapeutics.com/

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines known as Bicycle® molecules. These are fully synthetic bicyclic peptides engineered to combine the targeting specificity and pharmacological properties of large molecule biologics with the rapid and deep tissue penetration of small molecules. The company's proprietary platform creates precision-guided therapeutics to address diseases underserved by existing treatments. The primary focus of its development pipeline is in oncology, with a portfolio of candidates designed to target solid tumors. Beyond oncology, Bicycle Therapeutics leverages its technology through collaborations to explore applications in other therapeutic areas, including anti-infectives, cardiovascular diseases, and central nervous system disorders.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2021-04-09 English
FORM 4 SUBMISSION
Director's Dealing
2021-04-08 English
FORM 4 SUBMISSION
Director's Dealing
2021-04-02 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text mentions a press release about progress updates on partnered programs, filed as an exhibit. There are no financial statements or detailed financial data included, and the document length is only 3371 characters, indicating it is a brief announcement rather than a full report. The content does not fit categories like Annual Report, Earnings Release, or Interim Report. It is a regulatory announcement of an event, which fits best under Regulatory Filings (RNS) as a general SEC filing that does not fit other specific categories.
2021-04-02 English
4 Filing
Director's Dealing
2021-04-02 English
FORM 4 SUBMISSION
Director's Dealing
2021-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.